Wearable Technology for Monitoring Respiratory Rate and SpO2 of COVID-19 Patients | Chapter 4 | Research Developments in Medicine and Medical Science Vol. 3

 This review surveyed the indicators of COVID-19 following, such as vitals, respiring condition, temperature, oxygen satiation (SpO2), and activity levels using wearable instruments. With a significant number of unexpected home deaths reported general due to coronavirus affliction 2019 (COVID-19), wearable technology has emerged as a design for monitoring this contamination. This systematic review used PubMed as the table, with the keywords “COVID-19”, “Diagnosis”, and “Wearable Devices”. The search was restricted to studies published between 31 December 2019, and 8 July 2022, as the universal occurred all along this period.  All types of articles accompanying the keywords “COVID-19”, “Diagnosis”, and “Wearable Devices” were screened. Four reviewers alone screened the articles against the fitness criteria and elicited the data utilizing a data charting form. A total of 56 items were on listening, of which 28 included SpO2 as a limit. Although wearable devices are active in the continuous monitoring of COVID-19 cases, further research on actual inmates is necessary to determine the effectiveness and effectiveness of wearable electronics before policymakers can mandate its use. Although research on the belongings of remote patient listening with pulse oximetry and signs of life on health consequences is lacking, wearable devices have the potential to preserve hospital possessions for patients who power benefit most from care intensification.

Author(s) Details:

Shizuko Takahashi,
Department of Biomedical Ethics, Faculty of Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan and Sanno Medical Center, 8-5-35 Akasaka, Minato-ku, Tokyo 107-0052, Japan.

Eisuke Nakazawa,
Department of Biomedical Ethics, Faculty of Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan.

Sakurako Ichinohe,
Department of Biomedical Ethics, Faculty of Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan.

Aru Akabayashi,
Department of Biomedical Ethics, Faculty of Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan and Department of Biochemistry and Biophysics, School of Medicine and Dentistry Center for RNA Biology, University of Rochester, 601 Elmwood Avenue, Rochester, NY 14642, USA.

Akira Akabayashi,
Department of Biomedical Ethics, Faculty of Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan and Department of Biochemistry and Biophysics, School of Medicine and Dentistry Center for RNA Biology, University of Rochester, 601 Elmwood Avenue, Rochester, NY 14642, USA.

Please see the link here: https://stm.bookpi.org/RDMMS-V3/article/view/9913